Change in renal function associated with drug treatment in heart failure: national guidance

Inhibitors of the renin–angiotensin–aldosterone (RAAS) system are cornerstones of the management of patients with heart failure with reduced left ventricular ejection fraction (HFrEF). However, RAAS inhibitors may cause decline in renal function and/or hyperkalaemia, particularly during initiation a...

Descripción completa

Detalles Bibliográficos
Autores principales: Clark, Andrew L, Kalra, Paul R, Petrie, Mark C, Mark, Patrick B, Tomlinson, Laurie A, Tomson, Charles RV
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6582720/
https://www.ncbi.nlm.nih.gov/pubmed/31118203
http://dx.doi.org/10.1136/heartjnl-2018-314158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6582720/
https://www.ncbi.nlm.nih.gov/pubmed/31118203
http://dx.doi.org/10.1136/heartjnl-2018-314158

Ejemplares similares